Overview

Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery

Status:
Withdrawn

Trial end date:
2021-12-01

Target enrollment:
0

Participant gender:
All

Summary

This research is being done to determine quantitative and qualitative differences in patients' post-operative pain levels following elective orthognathic surgery after the local administration of a liposomal bupivacaine injection. A primary objective is to determine whether using a liposomal bupivacaine injection placed locally at the conclusion of elective orthognathic surgery will decrease pain levels (as determined by VAS scores). A secondary objective is to examine whether using a long acting liposomal bupivacaine injection locally at the conclusion of elective orthognathic surgery leads to decreased use of narcotics post-operatively.

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Boston University

Treatments:

Bupivacaine
Narcotics

Criteria

Inclusion Criteria:

- males and females 18-40 years of age undergoing elective double jaw orthognathic
surgery

Exclusion Criteria:

- pregnancy

- known hypersensitivity to any local anesthetic